Brian Metcalf

2.4k total citations
18 papers, 578 citations indexed

About

Brian Metcalf is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Brian Metcalf has authored 18 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Brian Metcalf's work include Hemoglobinopathies and Related Disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Hemoglobin structure and function (3 papers). Brian Metcalf is often cited by papers focused on Hemoglobinopathies and Related Disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Hemoglobin structure and function (3 papers). Brian Metcalf collaborates with scholars based in United States. Brian Metcalf's co-authors include Christine Debouck, Peggy Scherle, Jordan S. Fridman, Timothy C. Burn, Stacey Shepard, James D. Rodgers, Yanlong Li, Min Wei, Jiacheng Zhou and Qiyan Lin and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Brian Metcalf

18 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Metcalf United States 10 221 153 136 91 84 18 578
Brent Douty United States 9 379 1.7× 153 1.0× 98 0.7× 167 1.8× 101 1.2× 14 607
Puranik Purushottamachar United States 18 669 3.0× 46 0.3× 165 1.2× 44 0.5× 145 1.7× 45 1.0k
Jos de Man Netherlands 13 262 1.2× 53 0.3× 50 0.4× 46 0.5× 122 1.5× 22 497
Nilla Avanzi Italy 15 459 2.1× 64 0.4× 120 0.9× 59 0.6× 263 3.1× 27 778
J. Thomson United Kingdom 11 268 1.2× 45 0.3× 30 0.2× 23 0.3× 97 1.2× 15 479
Anna A. Rybczynska Netherlands 12 402 1.8× 22 0.1× 74 0.5× 66 0.7× 93 1.1× 20 566
Nicole Willemsen‐Seegers Netherlands 11 229 1.0× 20 0.1× 45 0.3× 34 0.4× 99 1.2× 18 371
Jeffrey Tredup United States 10 191 0.9× 8 0.1× 109 0.8× 64 0.7× 71 0.8× 17 360
R.‐J. Kuban Germany 10 161 0.7× 14 0.1× 59 0.4× 75 0.8× 70 0.8× 27 403
Joy Bauch United States 12 456 2.1× 6 0.0× 172 1.3× 72 0.8× 182 2.2× 20 751

Countries citing papers authored by Brian Metcalf

Since Specialization
Citations

This map shows the geographic impact of Brian Metcalf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Metcalf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Metcalf more than expected).

Fields of papers citing papers by Brian Metcalf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Metcalf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Metcalf. The network helps show where Brian Metcalf may publish in the future.

Co-authorship network of co-authors of Brian Metcalf

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Metcalf. A scholar is included among the top collaborators of Brian Metcalf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Metcalf. Brian Metcalf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Burns, David, Chunhong He, Yunlong Li, et al.. (2022). Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1. Bioorganic & Medicinal Chemistry Letters. 73. 128884–128884. 1 indexed citations
2.
Partridge, James R., Abel Silva‐Garcia, Chul H. Yu, et al.. (2019). Structures of full-length plasma kallikrein bound to highly specific inhibitors describe a new mode of targeted inhibition. Journal of Structural Biology. 206(2). 170–182. 11 indexed citations
3.
Stubbs, Matthew C., Xiaoming Wen, Chu‐Biao Xue, et al.. (2018). Abstract 2938: In vivo assessment of the combination of the JAK1 selective inhibitor itacitinib with first- and second-generation EGFR inhibitors in models of non-small cell lung cancer. Cancer Research. 78(13_Supplement). 2938–2938. 3 indexed citations
4.
Hutchaleelaha, Athiwat, et al.. (2015). GBT440 Demonstrates High Specificity for Red Blood Cells in Nonclinical Species. Blood. 126(23). 2172–2172. 8 indexed citations
5.
6.
Dufu, Kobina, et al.. (2013). GTx011, a Potent Allosteric Modifier Of Hemoglobin Oxygen Affinity, Delays Polymerization and Prevents Sickling. Blood. 122(21). 316–316. 2 indexed citations
7.
8.
Fridman, Jordan S., Peggy Scherle, Robert J. Collins, et al.. (2011). Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation. Journal of Investigative Dermatology. 131(9). 1838–1844. 88 indexed citations
9.
Trujillo, John I., Wei Huang, Robert Hughes, et al.. (2011). Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs. Bioorganic & Medicinal Chemistry Letters. 21(6). 1827–1831. 4 indexed citations
10.
Li, Yunlong, Eric Shi, David Burns, et al.. (2009). Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety. Bioorganic & Medicinal Chemistry Letters. 19(17). 5037–5042. 5 indexed citations
11.
Burns, David, Yunlong Li, Eric Shi, et al.. (2009). Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition. Bioorganic & Medicinal Chemistry Letters. 19(13). 3525–3530. 4 indexed citations
12.
Yue, Eddy W., Brent Douty, Brian Wayland, et al.. (2009). Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model. Journal of Medicinal Chemistry. 52(23). 7364–7367. 187 indexed citations
13.
Lin, Qiyan, David Meloni, Yongchun Pan, et al.. (2009). Enantioselective Synthesis of Janus Kinase Inhibitor INCB018424 via an Organocatalytic Aza-Michael Reaction. Organic Letters. 11(9). 1999–2002. 117 indexed citations
14.
Burns, David, Chunhong He, Yanlong Li, et al.. (2007). Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1′ permutations. Bioorganic & Medicinal Chemistry Letters. 18(2). 560–564. 13 indexed citations
15.
Zhuo, Jin‐Cong, Wenqing Yao, David Burns, et al.. (2007). Asymmetric Synthesis of Conformationally Constrained trans-2,3-Piperidinedicarboxylic Acid Derivatives. Synlett. 2007(3). 460–464. 9 indexed citations
16.
Metcalf, Brian & Rino Rappuoli. (2003). Pharmaceutical biotechnology. Current Opinion in Biotechnology. 14(6). 618–620. 11 indexed citations
17.
Debouck, Christine & Brian Metcalf. (2000). The Impact of Genomics on Drug Discovery. The Annual Review of Pharmacology and Toxicology. 40(1). 193–208. 78 indexed citations
18.
Casara, Patrick, Charles Darwin, Brian Metcalf, & Michel J. Jung. (1985). Stereospecific synthesis of (2R,5R)-hept-6-yne-2,5-diamine: a potent and selective enzyme-activated irreversible inhibitor of ornithine decarboxylase (ODC). Journal of the Chemical Society Perkin Transactions 1. 2201–2201. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brent Douty Breakdown of academic impact, for papers by Puranik Purushottamachar Breakdown of academic impact, for papers by Jos de Man Breakdown of academic impact, for papers by Nilla Avanzi Breakdown of academic impact, for papers by J. Thomson Breakdown of academic impact, for papers by Anna A. Rybczynska Breakdown of academic impact, for papers by Nicole Willemsen‐Seegers Breakdown of academic impact, for papers by Jeffrey Tredup Breakdown of academic impact, for papers by R.‐J. Kuban Breakdown of academic impact, for papers by Joy Bauch
Rankless by CCL
2026